|

Adipose Inflammation and Diabetes (FAB)

RECRUITINGSponsored by Göteborg University
Actively Recruiting
SponsorGöteborg University
Started2019-08-01
Est. completion2026-06-30
Eligibility
Age18 Years – 60 Years
View on ClinicalTrials.gov →

NCT04255264

Summary

The study investigates whether the addition of resolution molecules can inhibit inflammation and insulin resistance in human tissue taken from obese individuals, and whether the results of these studies correlate with patient-specific resolution phenotypes.

Eligibility

Age: 18 Years – 60 Years
Inclusion Criteria:

* BMI 30-40 kg/m2
* Ptos (i.e. excess skin) \> 3 cm
* Patient underwent gastric bypass surgery \>2 years ago
* Patient has had a stable weight ≥6 months at the time of operation
* Patient does not smoke (min 6 weeks prior to surgery)

Exclusion Criteria:

* Patients who do not understand spoken and written Swedish
* American Society of Anesthesiologists (ASA) classification ≥ 3
* Neurological, orthopedic or rheumatologic injury or illness affecting physical ability
* Preoperatively known hernia requiring surgical operation
* Severe mental illness

Conditions2

DiabetesObese

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.